PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
12-Sep-2022 Spotlight Therapeutics Appoints Nallakkan Arvindan, Ph.D., MBA, as EVP and Chief Technology Officer Businesswire
12-Sep-2022 Hygieia adds clinical partners in New York and North Carolina to its d-Nav® Insulin Management Program Businesswire
12-Sep-2022 L’étude de phase III évaluant trifluridine/tipiracil en association au bevacizumab chez des patients ayant un cancer colorectal métastatique réfractaire a atteint son objectif principal d’amélioration de survie globale Businesswire
12-Sep-2022 Drug Combination Meets Survival Endpoint in Phase III Pivotal Trial Involving Participants With Refractory Metastatic Colorectal Cancer Businesswire
12-Sep-2022 Can-Fite: New Phase III Psoriasis Data Showing Superior Safety & Improved Efficacy Presented by KOL Dr. Papp at the 31st European Academy of Dermatology Businesswire
12-Sep-2022 Nimbus Therapeutics Closes $125M Private Financing to Advance Clinical Programs in Autoimmune Diseases and Oncology Businesswire
12-Sep-2022 Drug Combination Meets Survival Endpoint in Phase III Pivotal Trial Involving Participants With Refractory Metastatic Colorectal Cancer Servier, Taiho Oncology, Inc., and Taiho Pharmaceutical Co., Ltd
12-Sep-2022 Fierce Biotech names STORM Therapeutics as one of its “Fierce 15” Biotech Companies of 2022 Fierce Biotech
12-Sep-2022 NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin to Showcase DERMAdoctor’s Eczema Balm on Return QVC® Appearance Businesswire
12-Sep-2022 TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers Businesswire
12-Sep-2022 ANI Pharmaceuticals Appoints Krista Davis as Chief Human Resources Officer Businesswire
12-Sep-2022 Enterome presents further efficacy data on its new generation therapeutic cancer vaccine EO2401 at ESMO Congress, demonstrating ability of OncoMimics™ antigens to generate positive clinical outcome Enterome
12-Sep-2022 SiSaf Announces Positive Preclinical Data in its SiS-ADO2 siRNA Program to Treat Rare Genetic Bone Disorder Osteopetrosis SiSaf
12-Sep-2022 Transgene Confirms the Potential of the Intravenous Route of its Invir.IO™ Oncolytic Viruses against Solid Tumors with TG6002 Phase I Data Presented at ESMO Congress 2022 Transgene
12-Sep-2022 Dermatology Devices Market Is Predicted To Reach US$ 39 Billion By 2031 MARKITWIRED Latest Market Reports
12-Sep-2022 Huntington’s Disease Treatment Market Is Expected To Reach US$ 432 Mn By 2022 End MARKITWIRED Latest Market Reports
12-Sep-2022 Global Market For Medical Device Complaint Management To Be Valued At US$ 5.35 Bn In 2022 MARKITWIRED Latest Market Reports
12-Sep-2022 Demand For Poultry Diagnostics Is Projected To Witness Growth Over Coming Years MARKITWIRED Latest Market Reports
12-Sep-2022 Sales Of Surgical Lasers Are Projected To Reach A Valuation Of US$ 1 Billion By 2031 MARKITWIRED Latest Market Reports
12-Sep-2022 Key Trends That Will Define Butyryl Chloride Market Research 2022-2030- Market.Biz Wired Release